Karpus Management, Inc. Pfizer Inc Transaction History

Karpus Management, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 15, 2023	BUY	$41.75 - $54.5 $168,670 - $220,180	4,040 New	4,040 $207,000
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $166,932 - $247,450	4,040 New	4,040 $239,000
Q3 2019 Oct 16, 2019	SELL	$32.49 - $42.13 $207,026 - $268,452	-6,372 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$36.98 - $41.52 $5,066 - $5,688	-137 Reduced 2.1%	6,372 $276,000
Q4 2018 Feb 14, 2019	BUY	$38.47 - $43.86 $250,401 - $285,484	6,509 New	6,509 $274,000
Q3 2018 Nov 14, 2018	SELL	$34.47 - $41.81 $191,963 - $232,839	-5,569 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$32.98 - $35.16 $183,665 - $195,806	5,569 New	5,569 $207,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Karpus Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Karpus Management, Inc. with notifications on news.